Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People's Republic of China.
Frequently asked questions
What sector does Genex Pharmaceutical Inc (GENX) operate in?
Genex Pharmaceutical Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Genex Pharmaceutical Inc (GENX) current stock price?
As of the latest data, Genex Pharmaceutical Inc stock price is $0.00, with a previous close of $0.00.
What is Genex Pharmaceutical Inc (GENX) current market capitalization?
Genex Pharmaceutical Inc market cap is approximately 110.60 thousand.
Does Genex Pharmaceutical Inc (GENX) pay dividends?
No. Genex Pharmaceutical Inc does not pay a dividend.
What is Genex Pharmaceutical Inc (GENX) beta (volatility) score?
Genex Pharmaceutical Inc has a beta of -52.293, indicating lower volatility than the overall market.